Clinical pharmacology of CNS 1102 in man

Ann N Y Acad Sci. 1995 Sep 15:765:336-7. doi: 10.1111/j.1749-6632.1995.tb16609.x.

Authors

K W Muir¹, D G Grosset, K R Lees

Affiliation

¹ University Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary, Glasgow, Scotland.

PMID: 7486638
DOI: 10.1111/j.1749-6632.1995.tb16609.x

No abstract available

Publication types

Clinical Trial
Comparative Study
Randomized Controlled Trial

MeSH terms

Brain Injuries / drug therapy
Cardiovascular System / drug effects*
Cerebrovascular Circulation / drug effects*
Cerebrovascular Disorders / drug therapy
Cross-Over Studies
Dose-Response Relationship, Drug
Double-Blind Method
Excitatory Amino Acid Antagonists / pharmacokinetics
Excitatory Amino Acid Antagonists / pharmacology*
Excitatory Amino Acid Antagonists / toxicity
Guanidines / pharmacokinetics
Guanidines / pharmacology*
Guanidines / toxicity
Humans
Male
Neuroprotective Agents / pharmacokinetics
Neuroprotective Agents / pharmacology*
Neuroprotective Agents / toxicity

Substances

Excitatory Amino Acid Antagonists
Guanidines
Neuroprotective Agents
aptiganel